Disease activity in Japanese sarcoidosis patients is generally mild. However, the pulmonary sarcoidosis coexisting with connective tissue disease is likely to be progressive. Wereport here three cases of sarcoidosis coexisting with connective tissue diseases, who developed pulmonary manifestations from stage II to stage III. (Internal Medicine 38: 984-987, 1999) 
Introduction
Sarcoidosis is a multisystem granulomatous disease of unknownetiology. Abnormalimmunefunction, such as positive rheumatoid factor (RF) and antinuclear antibodies (ANA), and pulmonary involvement that mayprogress from alveolitis to pulmonary fibrosis are frequently observed in sarcoidosis, as well as in connective tissue diseases. Therefore, similar immunopathogenic mechanisms have been considered in both conditions, but there are relatively few reports of sarcoidosis patients associated with connective tissue diseases (1) (2) (3) . Wedescribe three patients with sarcoidosis and coexistent connective tissue diseases, including rheumatoid arthritis, Sjogren's syndrome, and systemic sclerosis.
Case Report Case1
A 73-year-old womanwith sarcoidosis was admitted to our hospital due to a 4-month history of bilateral knee and wrist arthralgia. Six years before admission, she was diagnosed as having sarcoidosis by the presence of bilateral hilar lymphadenopathy (BHL) and multiple small nodular shadows in chest X-ray (sarcoidosis Stage II), high serum level of angiotensin-converting enzyme (s-ACE), and typical histological findings of a transbronchial lung biopsy specimen. Rheumatoid factor and antinuclear antibody were negative, and she had no joint symptoms at that time. Physical examination revealed joint swelling and pain of the metacarpophalangeal (MCP), proximal interphalangeal (PIP), and wrist joints of both hands. Blood examination showed an elevated erythrocyte sedimentation rate (ESR) 80 mm/hand Creactive protein (CRP) 2.9 mg/dl, and positive RF 452.5 IU/Z (normal <6 IU//), which had changed from negative 2 months before admission, and positive ANA(1:320, speckled). The hand X-ray showed erosive change between the trapezium and first metacarpal joints and the chest X-ray showed reticulonodular shadows and honeycombingin the middle to lower fields (Stage III, Fig. 1 and nonsteroidal anti-inflammatory drugs (NSAIDs), was started. Twomonths after administration of MTX,the patient's joint symptoms had almost disappeared, associated with a decrease in the CRP level to 0.7 mg/dl.
Case2
A 48-year-old womanwith systemic sclerosis was admitted to our hospital complaining of dyspnea and died of respiratory failure one month later. Whenshe was 29 years old, she was diagnosed as having generalized systemic sclerosis by the presence of Raynaud's phenomenon, proximal sclerodermatous skin changes, sclerodactyly, desquamative skin change, and pulmonary fibrosis. Although chest X-rays showed BHL and small nodular shadows (sarcoidosis Stage II, Fig. 2A ), she was not diagnosed as having sarcoidosis at that time. Four years later, the biopsy specimen of the right supraclavicular lymph node revealed noncaseating granuloma consistent with sarcoidosis, and thus sarcoidosis was histopathologically diagnosed. Serological examination showed positive ANA(1 : 160, speckled) with negative anti-RNP antibodies. Whenshe was 45 years old, exertional dyspnea increased and chest X-ray showed diffuse
Sarcoidosis & Connective Tissue Disease interstitial fibrotic changes with restrictive pulmonary dysfunction (Stage III, Fig. 2B ). Three years later, the pulmonary fibrosis had progressed (Fig. 2C) , and the patient died of respiratory failure.
Case3
A 58-year-old woman with a 7-month history of keratoconjunctivitis sicca (KCS) and xerostomia was admitted to our hospital for evaluation of increasing dyspnea on exertion. Chest roentgenogram showed BHLand reticular nodular shadows in both upper and middle lung fields (Stage II, Fig. 3A ). Blood examination revealed elevated levels of liver-associated enzyme and s-ACE. Transbronchial lung biopsy and liver biopsy specimens showed noncaseating granulomas consistent with sarcoidosis. KCSwas confirmed from a positive Shirmer's test and Rose-Bengal test. Biopsy of the minor salivary gland showed moderate lymphocytic infiltration without granuloma, consistent with Sjogren's syndrome. This patient was diagnosed as having sarcoidosis with lung and liver involvement and coexisting Sjogren's syndrome, therefore, high dose corticosteroids (PSL 60 mg/day) were administered. During therapy, osteoporotic change and lumbar fractures, which were considered as side effects of corticosteroids, were observed. Cyclophosphamide was added with a gradual lowering of corticosteroids and liver function steadily improved. However, the fibrotic changes in chest X-ray progressed and the chest roentgenogramtwo years later showedreticulonodular shadows (Stage III, Fig. 3B ).
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Discussion
Similarities between connective tissue diseases and sarcoidosis have been recognized since 1946 (5) and several authors have suggested shared immunopathogenicmechanisms (1, 2, 6). Sarcoidosis is considered to be an antigen-driven, Th l -mediated granulomatous disorder, dominated by expression of IFNy and IL12, and if the Thl response is not downregulated, active TGFpcould serve to promote fibrosis given its potent profibrotic effect (7) . Autoimmunediseases are also considered to be dependent on Thl or Th2 cells: rheumatoid arthritis is an example of a Thl dominant disorder and SLEshows a shift toward Th2 (8) . Although reports of coexisting sarcoidosis and connective tissue diseases are rare, sarcoidosis has been reported to be complicated with several types of connective tissue diseases including rheumatoid arthritis (9), systemic sclerosis (10), Sjogren's syndrome (ll), and systemic lupus erythematosus (SLE) ( 12). We described three cases (4%) of sarcoidosis complicated by rheumatoid arthritis (case 1 ), systemic sclerosis (case 2), or Sjogren's syndrome (case 3), from among73 sarcoidosis cases whowere admitted to our departmentover a 10-year period. All three were middle aged to elderly women (Table 1) . In case 1, rheumatoid arthritis was diagnosed six years after the onset of sarcoidosis. In case 2, systemic sclerosis was diagnosed four years before the diagnosis of sarcoidosis although the chest X-ray showed BHLat that time. In case 3, Sjogren syndrome and sarcoidosis were diagnosed simultaneously. In the reported association of rheumatoid arthritis and sarcoidosis, no patient with sarcoidosis subsequently developed rheumatoid arthritis, and case 1 was the first such case. Kucera (9) reported two cases with sarcoidosis in Stage I and Stage III which developed in patients with rheumatoid arthritis. Others (2, 13) have reported Stage I, II, and III cases, indicating any stage may be observed. Interestingly, when case 1 was diagnosed as RA, BHLwas disappearing and fibrotic change in the interstitium was progressing; this indicated it was developing from Stage II to Stage III. In a majority of the reported cases with coexistent systemic sclerosis and sarcoidosis (10, 14) , sarcoidosis was diagnosed several years after the onset of systemic sclerosis, as in the present case 2. It is reported that sarcoidosis associated scleroderma appeared to be severe and persistent, and the possibility of a common cause of sarcoidosis and scleroderma, in particular, the role of exposure to silica was suggested (14) . In case 2, no common cause of systemic scleroderma and sarcoidosis was found, but 986 Internal Medicine Vol. 38, No. 12 (December1999) the clinical symptomswere severe. Althoughthe diagnosis of sarcoidosis was confirmedfour years after the diagnosis of systemic scleroderma, BHLand paratracheal lymph node swelling with pulmonary fibrosis were found when the diagnosis of systemic sclerosis was first carried out. At that time, these findings were considered as lung involvement of progressive systemic sclerosis. After the diagnosis of sarcoidosis, the lymph node swelling disappeared and the fibrotic change in the lung field progressed and finally the patient died of respiratory failure. As a pulmonary manifestation in systemic sclerosis, BHL or paratracheal lymph node swelling are rare. Thus, if they are observed, coexistence of sarcoidosis should be considered. Since both sarcoidosis and Sjogren syndrome cause glandular involvement and sicca features, biopsy of labial minor salivary glands is a highly discriminatory method of distinguishing between sarcoidosis and Sjogren's syndrome. Case 3 was primary Sjogren syndrome accompanying severe liver sarcoidosis and progressive pulmonary sarcoidosis. It is reported that the chest roentgenogram showed BHLin 45%of coexisting cases with Sjogren syndrome and sarcoidosis, interstitial pneumonia in 27%, and no abnormality in 36% (2, 15) . In the present case, although the liver function was improving due to treatment with corticosteroids and cyclophosphamide, the pulmonary lesion was progressing slowly. With regard to the severity and activity of sarcoidosis, case 1 was mild, but the pulmonary lesion was progressive. In case 2, although the evaluation of the cause of the severe pulmonary fibrosis was difficult, it might be considered that coexistent systemic sclerosis and active sarcoidosis induced severe pulmonary fibrosis. In case 3, liver sarcoidosis was clinically severe and active, and pulmonary lesions were progressive even under the treatment of corticosteroids and immunosuppressants.In all three cases, pulmonary sarcoidosis was progressive and case 2 died of pulmonary fibrosis. It is distinctive compared with reported general prognosis for sarcoidosis: only 14% (16) (p=0.00343, Fisher's exact test) or 19.3% (17) (p=0.00947, Fisher's exact test) of Stage II patients progressed to Stage III. Of course, we could not exclude the possibility that the progressing pulmonary lesions were due to the associated connective tissue diseases in these patients, since pathological re-evaluation of interstitial infiltrates is uncommon in patients with definite diagnosis of sarcoidosis. However, considering the hypothesis that evolution of Thl immuneresponse into Th2 response could be associated with an increased risk of developing fibrocystic changes in sarcoidosis (7) and autoimmune diseases are dependent on a delicate balance between Thl and Th2 cells (8) , association of connective tissue diseases in sarcoidosis patients could be the juncture of developing fibrosis.
In general, disease activity in Japanese sarcoidosis cases is mild and almost all pulmonary lesions will regress spontaneously. However,the sarcoidosis coexisting with connective tissue disease showed high activity and especially the pulmonary lesions were progressive from the BHLstage to the fibrotic stage. Progressive pulmonary sarcoidosis would suggest possibly coexisting connective tissue diseases.
